期刊文献+

甲状腺乳头状癌血清代谢组学研究 被引量:3

Analyze the metabolite composition of serum samples from patients with papillary thyroid carcinoma
原文传递
导出
摘要 目的 分析甲状腺乳头状癌组(T组)及健康对照组(H组)血清代谢组学差异.方法 收集血清样本,采集图谱.利用Topspin、AMIX及SIMCA-P+软件进行图谱分析、数据积分并进行主成分分析及偏最小二乘判别分析,分析两组血清的内源性代谢差异.结果 以T组和H组数据建立判别模型,经交叉验证和排列实验验证,模型成立(P<0.05);T组中缬氨酸、亮氨酸、异亮氨酸、乳酸、丙氨酸、谷氨酸、赖氨酸、甘氨酸含量升高;脂类、胆碱、酪氨酸含量下降.结论 T组与H组之间存在明显的代谢差异.T组代谢异常不仅涉及糖代谢,而且涉及脂类、氨基酸及核酸代谢. Objective Analysis the metabolic differences among the papillary thyroid carcinoma group (T group) and healthy controls group (H group) by nuclear magnetic resonance hydrogen spectrum.Methods Collecting the serum specimen,Analysis the serum specimen.To phase and baseline correction use Topspin software,to integral use AMIX software.Analysis the differences about endogenous metabolites between the T group and H group by principal component analysis (PCA) and parialleast square-discrimina (PLS-DA) with SIMCA-P + software.Results According to the data of T group and H group,discrimination model is established.By the PLS-DA cross validation and permutation test proving,the model is correct (P 〈 0.05).The content of metabolites in the serum of T group are increased including valine,leucine,isoleucine,lactic acid,alanine,glutamic acid,lysine,glycine,but the lipids,choline,tyrosine are reduced.Conclusion There is an obvious metabolic difference between T and H group.The difference is not only involve glucose metabolism but also the metabolism of lipid,amino acids and nucleic acid.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第11期2545-2547,共3页 Chinese Journal of Experimental Surgery
基金 福建省自然科学基金资助项目(2012J01355) 福建省卫生系统中青年骨干人才培养项目(2013-ZQN-ZD-13) 国家临床重点专科建设项目 福建省医学临床重点学科
关键词 甲状腺乳头状癌 代谢组学 血清 核磁共振氢谱 Papillary thyroid carcinoma Metabonomics Serum Nuclear magnetic resonance 1H spectroscopy
  • 相关文献

参考文献16

  • 1Greenlee RT,Hill-Harmon MB,Murray T,et al.Cancer statistics,2001[J].CA Cancer J Clin,2001,51 (1):15-36. 被引量:1
  • 2Yu GP,Li JC,Branovan D,et al.Thyroid cancer incidence and survival in the national cancer institute surveillance,epidemiology,and end results race/ethnicity groups[J].Thyroid,2010,20(5):465-473. 被引量:1
  • 3Siegel R,Naishadham D,Jemal A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-33. 被引量:1
  • 4Hundahl SA,Fleming ID,Fremgen AM,et al.A national cancer date base report on 53,856 cases of thyroid carcinoma treated in the US,1985-1995[J].Cancer,1998,83 (12):2638-2648. 被引量:1
  • 5Nicholson JK,Connelly J,Lindon JC,et al.Metabonomics:aplatform for studying drug toxicity and gene function[J].Nat Rev Drug Discover,2002,1 (2):153-161. 被引量:1
  • 6Odunsi K,Wollman RM,Ambrosone CB,et al.Detection of epithelial ovarian cancer using 1 H-NMR-based metabonomics[J].Int Cancer,2005,113 (5):782-788. 被引量:1
  • 7Gao HC,Lu Q,Liu X,et al.Applicaton of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis[J].Cancer Sci,2009,1 00 (4):782-785. 被引量:1
  • 8Tran T,Toss B,Lin A.Magnetic resonance spectroscopy in neurological diagnosis[J].Neurol Clin,2009,27(1):21-25. 被引量:1
  • 9Jinglin Z,Bin X,Jing H,et al.1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma[J].Clin Chim Acta,2009,401 (1-2):8-13. 被引量:1
  • 10Paolo M,Liborio T,Laetitia S,et al.Metabolomics approach to thyroid nodules-a high-resolution magic-angle spinning nuclear magnetic resonance-based study[J].Surgery,2012,152 (6):1118-1124. 被引量:1

二级参考文献33

  • 1Woodruff SL,Arowolo OA,Akute OO,et al. Global variation in the pattern of differentiated thyroid cancer. Am J Surg,2010 ,200 :462-466. 被引量:1
  • 2Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA ,2006,295:2164-2167. 被引量:1
  • 3Wang JY, Yang IP, Wu DC, et al. Functional glutathione peroxidase 3 polymorphisms associated with increased risk of Taiwan Residents patients with gastric cancer. Clin Chim Acta,2010,411 : 1432-1436. 被引量:1
  • 4Brigelius-Flohe R, Kipp A. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta,2009,1790 : 1555-1568. 被引量:1
  • 5Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet, 1999,21:163-167. 被引量:1
  • 6Paz MF, Fraga MF, Avila S, et al. A systematic profile of DNA methyl- ation in human cancer cell lines. Cancer Res,2003,63 : 1114-1121. 被引量:1
  • 7Fleisher AS, Esteller M, Tamura G, et al. Hypermethylation of the bMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene ,2001,20:329-335. 被引量:1
  • 8Catteau A, Morris JR. BRCA1 methylation:A significant role in tumour development? Semin Cancer Bio1,2002 ,12 :359-371. 被引量:1
  • 9Alvarez-Nunez F, Bussaglia E, Mauricio D, et al. PTEN promoter methylation in sporadic thyroid carcinomas. Thyroid ,2006,16 : 17-23. 被引量:1
  • 10Xing M, Cohen Y, Mambo E, et al. Early occurrence of RASSF1A hy- permethylation and its mutual exclusion with BRAF mutation in thy- roid tumorigenesis. Cancer Res,2004,64 : 1664-1668. 被引量:1

共引文献12

同被引文献28

  • 1Siegel R, Naishadham D, Jernal A. Cancer statistics, 2013 [ J ]. CA Cancer J Clin ,2013,63 ( 1 ) : 11-30. 被引量:1
  • 2Beekonert O, Keun HC, Ebbels TM, et al. Metabolic profiling metabo- lomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts [ J ]. Nat Protoc, 2007,2 ( 11 ) : 2692-27O3. 被引量:1
  • 3Yin P,Wan D,Zhao C,et al. A metabonomic study of hepatitis B-in- duced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry [ J]. Mol Biosyst, 2009,5 (8) : 868-876. 被引量:1
  • 4DeBerardinis RJ,Lum J J, Hatzivassihou G, et al. The biology of canc- er:metabolic reprogramming fuels cell growth and proliferation [ J ]. Cell Metab ,2008,7 ( 1 ) : 11-20. 被引量:1
  • 5Warburg O, Wind F,Negelein E. The metabolism of tumors in the body[ J]. J Gen Physiol, 1927,8 (6) :519-530. 被引量:1
  • 6Linker RA, Lee DH, Ryan S, et al. Fumarie acid esters exert neuropro- tective effects in neuroinflammation via activation of the Nrf2 antioxi- dant pathway [ J ]. Brain,2011,134 ( Pt 3 ) :678-692. 被引量:1
  • 7Wang X, Yan SK, Dai WX, et al. A metabonomic approach to chemo- sensitivity prediction of Cisplatin plus 5-fluorouracil in a human xeno- graft model of gastric cancer[ J]. Int J Cancer,2010,127 ( 12 ) :2841 - 2850. 被引量:1
  • 8黄焕军,王敏,秦仁义,申铭,江建新,朱峰,田锐.人胰腺癌干细胞差异性基因的表达[J].中华实验外科杂志,2009,26(7):845-848. 被引量:5
  • 9危阳洋,王彩虹,李伟,董继扬,陈忠.甲亢患者血清和尿液的核磁共振代谢组学研究[J].高等学校化学学报,2010,31(2):279-284. 被引量:17
  • 10闫忠芳,陆伟.不平衡氨基酸抑瘤作用研究进展[J].国际肿瘤学杂志,2011,38(3):192-194. 被引量:1

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部